Skip to main content
Clinical Trials/NCT05324215
NCT05324215
Unknown
N/A

Effects of Transversalis Fascia Plane Block and Rectus Sheath Block on Opioid Consumption in Renal Transplantation Donors

Koc University Hospital1 site in 1 country50 target enrollmentFebruary 17, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
Koc University Hospital
Enrollment
50
Locations
1
Primary Endpoint
Total opioid consumption retrieved from patient records
Last Updated
4 years ago

Overview

Brief Summary

Transversalis fascia plane block (TFPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. It has been shown that TFPB and rectus sheath block (RSB) administration reduces opioid consumption and related side effects in patients undergoing surgery with general anesthesia. To our knowledge, there is no study examining TFPB in donor nephrectomy.

The investigators aimed to prospectively examine the effect of TFPB and RSB on opioid consumption in postoperative period on donors who will undergo laparoscopic nephrectomy in renal transplantation surgery.

Registry
clinicaltrials.gov
Start Date
February 17, 2022
End Date
February 17, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Koc University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Özlem Özkalaycı

Principal Investigator

Koc University Hospital

Eligibility Criteria

Inclusion Criteria

  • Donor patients scheduled for elective nephrectomy in renal transplantation surgery
  • American Society of Anesthesiologists (ASA) I-II
  • Patients who are aged between 18-75

Exclusion Criteria

  • Skin infection at the block area
  • Coagulation disorder and using anticoagulant drugs
  • End-stage organ and system failure
  • Severe pulmonary and/or cardiovascular problems
  • Substance addiction or known psychiatric or mental problems
  • Chronic painkiller usage

Outcomes

Primary Outcomes

Total opioid consumption retrieved from patient records

Time Frame: up to 24 hours

the amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours.

Secondary Outcomes

  • Numeric Rating Scale (NRS)(up to 24 hours)

Study Sites (1)

Loading locations...

Similar Trials